More about the combination of rituximab, cyclosporine and dexamethasone in the treatment of chronic ITP. A useful option on an environment with limited resources

More about the combination of rituximab, cyclosporine and dexamethasone in the treatment of chronic ITP. A useful option on an environment with limited resources

Research Abstract
NULL
Research Authors
AF Thabet, SM Moeen
Research Department
Internal Medicine
Research Journal
platelets
Research Member
Ahmad Farrag Thabet Farrag
Research Pages
784-787
Research Publisher
Taylor & Francis
Research Rank
1
Research Vol
17;31(6)
Research Website
NULL
Research Year
2020